Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sleep Wake Disorders 1 Radiation Injuries 1 Pinealoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Meningioma 1 Medulloblastoma 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Fatigue 1 Ependymoma 1 Depression 1 Craniopharyngioma 1 Cognition Disorders 1 Chronic Pain 1 Choroid Plexus Neoplasms 1 Central Nervous System Neoplasms 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Anxiety Disorders 1

Interventions

siltuximab 1 nabiximols 1 erenumab 1 Sufentanil 1 Standard of Care 1 Saline Solution 1 Pain Management 1 Medical Marijuana 1 Donepezil 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chronic Pain × Donepezil × Clear all

NCT05254639 2024-04-05

DONEPEZOX

University Hospital, Clermont-Ferrand

Phase 2 Completed

Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡